UIM1:XETRA:XETRA-UBS ETF SICAV - Euro Stoxx 50 UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 49.72

Change

+0.10 (+0.19)%

Market Cap

USD 0.49B

Volume

2.61K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-02 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.23 (-0.43%)

USD 501.76B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.06 (-0.36%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.18 (-0.64%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.11 (-0.37%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.01 (-0.02%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

+0.88 (+0.62%)

USD 101.19B
JARI:XETRA Amundi Index Solutions - Amund..

-0.21 (-0.45%)

USD 100.74B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.13 (-0.26%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.32 (+0.33%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+2.04 (+0.37%)

USD 80.38B

ETFs Containing UIM1:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.77% 49% F 52% F
Dividend Return 3.25% 87% B+ 69% C-
Total Return 12.02% 60% D- 61% D-
Trailing 12 Months  
Capital Gain 20.66% 54% F 57% F
Dividend Return 3.60% 84% B 66% D+
Total Return 24.27% 67% D+ 67% D+
Trailing 5 Years  
Capital Gain 44.37% 61% D- 63% D
Dividend Return 10.68% 89% A- 57% F
Total Return 55.04% 69% C- 68% D+
Average Annual (5 Year Horizon)  
Capital Gain 10.32% N/A N/A 70% C-
Dividend Return 11.94% N/A N/A 74% C
Total Return 1.61% N/A N/A 62% D
Risk Return Profile  
Volatility (Standard Deviation) 15.59% N/A N/A 45% F
Risk Adjusted Return 76.59% N/A N/A 80% B-
Market Capitalization 0.49B 65% D 57% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike